SARS CoV-2 Spike Glycoprotein Brazil variant Blocking Peptide for STJ506298 peptide (Brazil variant) (STJ506301)

SKU:
STJ506301-250

Shipping:
Free Shipping
Current Stock:
Applications: Immunodepletion/Immunocompetition
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: SARS CoV-2 Spike Glycoprotein Brazil variant Blocking Peptide for STJ506298 is synthetically produced from the 400-450 sequence about the Brazil variant and is suitable for use in western blot applications.
Formulation: Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Immunogen Region: 400-450
Specificity: This blocking peptide is recommended for use in combination with SARS CoV-2 Spike Glycoprotein Brazil variant antibody, STJ506298
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance